Two Indicted In Alleged International Counterfeit Ozempic Smuggling Scheme
On September 29, 2026, a federal indictment unsealed in the Middle District of Florida charged Swapnadip Roy, 33, and Vicky Ramancha, 37, in an alleged international scheme to smuggle and sell counterfeit Ozempic.[1]
Roy appeared in federal court that day after being extradited from Italy, while Ramancha remained at large, prosecutors said.[1] The indictment charges each defendant with one conspiracy count, three counts of smuggling and two counts related to selling or holding counterfeit drugs.[1] Prosecutors say the counts together carry a maximum possible sentence of 71 years in prison.[1]
Authorities allege Roy and Ramancha smuggled and sold thousands of counterfeit Ozempic units manufactured by unauthorized companies in China into the United States between July 2023 and April 2024.[1] A March 2024 shipment of about 11,000 counterfeit units was allegedly sent to an Ohio warehouse, with other distributions routed to companies in Florida.[1]
Federal prosecutors in the Middle District of Florida are handling the case, and authorities continue to seek Ramancha.[1]
Show source details & analysis (1 source)
📌 Key Facts
- On September 29, 2026, an indictment was unsealed in the Middle District of Florida charging Swapnadip Roy, 33, and Vicky Ramancha, 37, in a counterfeit Ozempic scheme.
- Roy and Ramancha are accused of smuggling and selling thousands of counterfeit Ozempic units from unauthorized manufacturers in China into the U.S. between July 2023 and April 2024.
- Roy appeared in federal court on September 29, 2026, after extradition from Italy, while Ramancha remains at large.
- The indictment alleges a March 2024 shipment of about 11,000 counterfeit units to an Ohio warehouse and other distributions to companies in Florida.
- Each defendant faces one conspiracy charge, three smuggling counts, and two counts related to selling or holding counterfeit drugs, with a maximum possible penalty of 71 years in prison.
📰 Source Timeline (1)
Follow how coverage of this story developed over time